Rice Hall James & Associates’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.88M | Sell |
68,223
-5,572
| -8% | -$317K | 0.21% | 103 |
|
|
2025
Q1 | $4.14M | Sell |
73,795
-5,013
| -6% | -$281K | 0.24% | 89 |
|
|
2024
Q4 | $4.84M | Sell |
78,808
-4,530
| -5% | -$278K | 0.27% | 82 |
|
|
2024
Q3 | $5.58M | Buy |
83,338
+16,297
| +24% | +$1.09M | 0.3% | 77 |
|
|
2024
Q2 | $4.48M | Buy |
67,041
+2,427
| +4% | +$162K | 0.27% | 82 |
|
|
2024
Q1 | $4.59M | Sell |
64,614
-40,397
| -38% | -$2.87M | 0.26% | 85 |
|
|
2023
Q4 | $8.84M | Sell |
105,011
-6,623
| -6% | -$558K | 0.51% | 52 |
|
|
2023
Q3 | $9.6M | Sell |
111,634
-1,365
| -1% | -$117K | 0.61% | 46 |
|
|
2023
Q2 | $10.5M | Sell |
112,999
-1,124
| -1% | -$105K | 0.6% | 49 |
|
|
2023
Q1 | $10.8M | Sell |
114,123
-243
| -0.2% | -$23K | 0.61% | 45 |
|
|
2022
Q4 | $11.5M | Sell |
114,366
-3,172
| -3% | -$319K | 0.66% | 43 |
|
|
2022
Q3 | $10M | Sell |
117,538
-1,352
| -1% | -$115K | 0.58% | 46 |
|
|
2022
Q2 | $10.2M | Buy |
118,890
+2,277
| +2% | +$196K | 0.49% | 56 |
|
|
2022
Q1 | $10.5M | Buy |
116,613
+2,780
| +2% | +$250K | 0.42% | 64 |
|
|
2021
Q4 | $11.4M | Sell |
113,833
-952
| -0.8% | -$95.2K | 0.4% | 59 |
|
|
2021
Q3 | $10.7M | Buy |
114,785
+1,896
| +2% | +$176K | 0.39% | 65 |
|
|
2021
Q2 | $9.6M | Sell |
112,889
-4,107
| -4% | -$349K | 0.34% | 67 |
|
|
2021
Q1 | $10.1M | Buy |
116,996
+12,921
| +12% | +$1.12M | 0.33% | 72 |
|
|
2020
Q4 | $8.77M | Buy |
104,075
+4,628
| +5% | +$390K | 0.31% | 70 |
|
|
2020
Q3 | $7.94M | Buy |
99,447
+27,163
| +38% | +$2.17M | 0.32% | 68 |
|
|
2020
Q2 | $6.41M | Buy |
72,284
+670
| +0.9% | +$59.4K | 0.28% | 101 |
|
|
2020
Q1 | $6.74M | Sell |
71,614
-9,252
| -11% | -$870K | 0.38% | 79 |
|
|
2019
Q4 | $8.73M | Buy |
80,866
+2,247
| +3% | +$242K | 0.3% | 110 |
|
|
2019
Q3 | $7.54M | Buy |
78,619
+566
| +0.7% | +$54.2K | 0.27% | 111 |
|
|
2019
Q2 | $7.47M | Buy |
78,053
+33,064
| +73% | +$3.16M | 0.25% | 115 |
|
|
2019
Q1 | $3.97M | Buy |
44,989
+21,407
| +91% | +$1.89M | 0.13% | 135 |
|
|
2018
Q4 | $1.96M | Buy |
23,582
+20,173
| +592% | +$1.68M | 0.07% | 169 |
|
|
2018
Q3 | $321K | Sell |
3,409
-12
| -0.4% | -$1.13K | 0.01% | 285 |
|
|
2018
Q2 | $377K | Buy |
3,421
+58
| +2% | +$6.39K | 0.01% | 276 |
|
|
2018
Q1 | $332K | Sell |
3,363
-509
| -13% | -$50.2K | 0.01% | 274 |
|
|
2017
Q4 | $315K | Buy |
3,872
+41
| +1% | +$3.34K | 0.01% | 284 |
|
|
2017
Q3 | $282K | Buy |
3,831
+2
| +0.1% | +$147 | 0.01% | 279 |
|
|
2017
Q2 | $277K | Buy |
3,829
+40
| +1% | +$2.89K | 0.01% | 276 |
|
|
2017
Q1 | $236K | Buy |
3,789
+114
| +3% | +$7.1K | 0.01% | 288 |
|
|
2016
Q4 | $267K | Buy |
+3,675
| New | +$267K | 0.01% | 282 |
|